These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21655930)

  • 1. Choosing a treatment for patients at the time a fracture is presented.
    Tanner SB
    Curr Osteoporos Rep; 2011 Sep; 9(3):156-9. PubMed ID: 21655930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-induced osteoporosis: management update.
    Adler RA
    Curr Osteoporos Rep; 2010 Mar; 8(1):10-4. PubMed ID: 20425085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological management of osteoporosis.
    Riek AE; Towler DA
    Mo Med; 2011; 108(2):118-23. PubMed ID: 21568234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ... Fracture prevention. New osteoporosis drug improves patient adherence.
    Jones KW; Bushardt RL
    JAAPA; 2010 Dec; 23(12):56, 60. PubMed ID: 21229838
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis].
    Varenna M; Gatti D
    Reumatismo; 2010; 62(3):163-71. PubMed ID: 21052563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2014 Mar; 24(3):401-6. PubMed ID: 24576937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc].
    Kawate H; Takayanagi R
    Clin Calcium; 2010 May; 20(5):744-51. PubMed ID: 20445286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer-lasting osteoporosis drugs sought.
    Kuehn BM
    JAMA; 2005 May; 293(20):2458. PubMed ID: 15914731
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ; Dixon T
    Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing options for the treatment of osteoporosis.
    Khosla S
    N Engl J Med; 2009 Aug; 361(8):818-20. PubMed ID: 19671654
    [No Abstract]   [Full Text] [Related]  

  • 11. Injection of hope.
    Elliott M
    Nurs Stand; 2010 Nov 10-16; 25(10):23. PubMed ID: 21155482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis diagnosis and medical treatment.
    Warriner AH; Saag KG
    Orthop Clin North Am; 2013 Apr; 44(2):125-35. PubMed ID: 23544819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr; 2010 Dec; 160(21-22):586-9. PubMed ID: 21170699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on osteoporosis treatment.
    Nogués X; Martinez-Laguna D
    Med Clin (Barc); 2018 Jun; 150(12):479-486. PubMed ID: 29179892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of glucocorticoid induced osteoporosis].
    Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis drug licensed for women with high fracture risk.
    Traynor K
    Am J Health Syst Pharm; 2010 Jul; 67(13):1046. PubMed ID: 20554585
    [No Abstract]   [Full Text] [Related]  

  • 18. The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them.
    Gasser JA
    Curr Opin Pharmacol; 2006 Jun; 6(3):313-8. PubMed ID: 16650802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab.
    Rizzoli R; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2010 Aug; 9(8):591-2. PubMed ID: 20671758
    [No Abstract]   [Full Text] [Related]  

  • 20. [Innovations in the treatment of osteoporosis].
    Tsourdi E; Hofbauer LC
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.